Your Source for Pharmaceutical Industry Intelligence
Basic Plancompare plans | |
| $275 / One Month | $975 / One Year |
 | |
   
| |
| Need an invoice? Group rate? Contact admin@DrugPatentWatch.com | |
Search for Patents Expiring in Apr 2010
Glossary
| Applicant | Tradename | Generic Name | NDA | Approval Date | Type | RLD | Patent Number | Product | Substance | Delist Req. | Patent Expiration | Patented / Exclusive Use |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Merck | HYZAAR | hydrochlorothiazide; losartan potassium | 020387 | Nov 10, 1998 | RX | Yes | 5,153,197*PED | Y | Apr 6, 2010 | TREATMENT OF HYPERTENSION | ||
| Merck | HYZAAR | hydrochlorothiazide; losartan potassium | 020387 | Apr 28, 1995 | RX | No | 5,153,197*PED | Y | Apr 6, 2010 | FIRST LINE TREATMENT OF SEVERE HYPERTENSION, IN PATIENTS WITH HYPERTENSION SEVERE ENOUGH THAT THE VALUE OF ACHIEVING PROMPT BLOOD PRESSURE CONTROL EXCEEDS THE RISK OF INITIATING COMBINATION THERAPY IN THESE PATIENTS | ||
| Merck | HYZAAR | hydrochlorothiazide; losartan potassium | 020387 | Apr 28, 1995 | RX | No | 5,153,197*PED | Y | Apr 6, 2010 | TREATMENT OF HYPERTENSION |
This preview shows a limited data set. Complete access is available with a Subscription
<- Back to Dashboard
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Copyright © 2000-2010, thinkBiotech LLC.
Follow DrugPatentWatch on Twitter![[del.icio.us]](/inc/bookmarkify/delicious.png)
![[Digg]](/inc/bookmarkify/digg.png)
![[Reddit]](/inc/bookmarkify/reddit.png)
![[Facebook]](/inc/bookmarkify/facebook.png)
![[LinkedIn]](/inc/bookmarkify/linkedin.png)
![[StumbleUpon]](/inc/bookmarkify/stumbleupon.png)
![[Technorati]](/inc/bookmarkify/technorati.png)
![[Twitter]](/inc/bookmarkify/twitter.png)
![[Email]](/inc/bookmarkify/email.png)